Flomics

Flomics introduces a liquid biopsy with cell-free long RNAs (cfRNAs) for the early detection of complex diseases, such as cancer. From a simple blood draw, an asymptomatic individual has the chance to be screened in a minimally invasive way and to understand if he/she needs to move on to more complex exploratory analysis. This is particularly important for individuals with >50 years of age, with family history, or high-risk populations, e.g. smokers.